Other Information.
−Removed: During the period ended March 31, 2025, none of our
−Removed: directors or executive officers adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading
−Removed: arrangement” (as each item is defined Item 408(a) of Regulation S-K).
+Added: the period ended June 30, 2025, none of our directors or executive officers adopted or terminated any “Rule 10b5-1 trading arrangement”
+Added: or “non-Rule 10b5-1 trading arrangement” (as each item is defined Item 408(a) of Regulation S-K).
Certificate of Incorporation of Kairos Pharma, Ltd.
9 unchanged sentences
Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: Inline XBRL Instance Document-the
−Removed: instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document.
−Removed: Inline XBRL Taxonomy Extension
−Removed: Inline XBRL Taxonomy Extension
−Removed: Calculation Linkbase.
−Removed: Inline XBRL Taxonomy Extension
−Removed: Definition Linkbase.
−Removed: Inline XBRL Taxonomy Extension
−Removed: Label Linkbase.
−Removed: Inline XBRL Taxonomy Extension
−Removed: Presentation Linkbase.
−Removed: Cover Page Interactive Data
−Removed: File (embedded within the Inline XBRL document and contained in Exhibit 101).
+Added: Services Agreement, dated June 10, 2025, between Kairos Pharma Ltd.
+Added: and Baretto Pacific Corporation (incorporated by reference to Exhibit 99.1 to the Current Report on Form 8-K dated June 12, 2025).
+Added: XBRL Instance Document-the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the
+Added: Inline XBRL document.
+Added: XBRL Taxonomy Extension Schema.
+Added: XBRL Taxonomy Extension Calculation Linkbase.
+Added: XBRL Taxonomy Extension Definition Linkbase.
+Added: XBRL Taxonomy Extension Label Linkbase.
+Added: XBRL Taxonomy Extension Presentation Linkbase.
+Added: Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).
Filed herewith.
Furnished herewith.
−Removed: Pursuant to the requirements of the Securities Exchange
−Removed: Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
−Removed: KAIROS PHARMA, LTD.
−Removed: Chief Executive Officer and Chairman of the Board of Directors (principal
−Removed: executive officer)
−Removed: /s/ Douglas Samuelson
+Added: to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
+Added: the undersigned, thereunto duly authorized.
+Added: August 12, 2025
+Added: Executive Officer and Chairman of the Board of Directors
+Added: (principal executive officer)
Douglas Samuelson
−Removed: Chief Financial Officer
−Removed: (Principal Financial and Accounting Officer)
+Added: Financial Officer
+Added: Financial and Accounting Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.